In mice, mutations in LRP5 were found to be associated with low BMD and abnormal retinal vasculature (36), while in humans, mutations in LRP5 were found to cause disorders characterized by high BMD and osteoporosis–pseudoglioma syndrome, causing severe osteoporosis and blindness (37). This evidence concerns the gene LRP5 and blindness (disorder).